Mark Uden
12Patents
3h-index
27Co-inventors
60Inventor score
Filing activity: Jun 8, 2000 → Aug 16, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7303910B2 | Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site | Chemistry; Metallurgy | 40 | Expired |
| US6783981B1 | Anti-viral vectors | Chemistry; Metallurgy | 21 | Expired |
| US6808922B1 | Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site | Chemistry; Metallurgy | 7 | Expired |
| US11203632B2 | Antibody variants | Chemistry; Metallurgy | 1 | Active |
| US9163249B2 | Production methods | Chemistry; Metallurgy | 1 | Active |
| US9534246B2 | Method for selecting high producing cell lines | Physics | 1 | Active |
| US10633673B2 | Production methods | Chemistry; Metallurgy | 0 | Active |
| US11566347B2 | Antibody variants | Chemistry; Metallurgy | 0 | Active |
| US11098312B2 | Method of producing a recombinant protein | Chemistry; Metallurgy | 0 | Active |
| US11254753B2 | Antibodies with reduced binding to process impurities | Chemistry; Metallurgy | 0 | Active |
| US12312408B2 | Multispecific anti-TCR delta variable 1 antibodies | Emerging Cross-Sectional Technologies | 0 | Active |
| US11667887B2 | Method of producing a recombinant protein | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.